The purpose of this study is to determine whether supplementation with phosphatidylcholine lowers plasma homocysteine concentrations in healthy men.
A high homocysteine concentration is a potential risk for cardiovascular disease. Plasma homocysteine concentrations can be lowered through betaine supplementation. However, effects of choline supplementation, the precursor for betaine, on plasma homocysteine concentrations in healthy humans are unknown. If supplementation with choline or phosphatidylcholine, the form in which choline occurs in foods, lowers homocysteine concentrations, then extra intake of these compounds may lower cardiovascular disease risk in humans. Comparison: We compared the effects of supplementation with phosphatidylcholine to the effects of a placebo on fasting and post-methionine concentrations of plasma homocysteine in healthy men.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
26
Wageningen Centre for Food Sciences
Wageningen, Netherlands
TNO Nutrition and Food Research
Zeist, Netherlands
Concentrations of plasma homocysteine in the fasting state
Concentrations of plasma homocysteine after a methionine load
Lipid concentrations
Liver enzymes
Creatinine
B-vitamins
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.